These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 1768309)

  • 1. Repartitioning effect of a mixed beta-agonist on body composition.
    Portillo MP; Martínez JA; Larralde J
    Rev Esp Fisiol; 1990 Jun; 46(2):191-6. PubMed ID: 1980376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of oral and subcutaneous administration of a mixed beta-adrenergic agonist on tissue and cell growth.
    Del Barrio AS; Rguez-Mariscal M; Martínez JA; Larralde J
    Growth Dev Aging; 1992; 56(3):141-8. PubMed ID: 1385342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.
    Kettelhut IC; Goldberg AL
    J Clin Invest; 1988 May; 81(5):1384-9. PubMed ID: 3163348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic effects of feeding beta2-adrenergic agonists on rainbow trout muscle proteases and proteins.
    Salem M; Levesque H; Moon TW; Rexroad CE; Yao J
    Comp Biochem Physiol A Mol Integr Physiol; 2006 Jun; 144(2):145-54. PubMed ID: 16580855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction-oxidation state and protein degradation in skeletal muscles of growing rats.
    Fagan JM; Tischler ME
    Growth; 1986; 50(2):139-46. PubMed ID: 3792902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein turnover and growth of L8 muscle cultures in serum from rats fed clenbuterol.
    McElligott MA; Chaung LY
    Growth Dev Aging; 1988; 52(4):185-91. PubMed ID: 3255725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tentative identification of the toxohormones of cancer cachexia: roles of vasopressin, prostaglandin E2 and cachectin-TNF.
    Siddiqui RA; Williams JF
    Biochem Int; 1990; 20(4):787-97. PubMed ID: 2353926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.
    Villicev CM; Freitas FR; Aoki MS; Taffarel C; Scanlan TS; Moriscot AS; Ribeiro MO; Bianco AC; Gouveia CH
    J Endocrinol; 2007 Apr; 193(1):21-9. PubMed ID: 17400799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle growth in lean and obese Zucker rats.
    Durschlag RP; Layman DK
    Growth; 1983; 47(3):282-91. PubMed ID: 6196256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolic pattern of muscle and liver after the administration of a beta-adrenergic agonist.
    Portillo MP; Martínez JA; Larralde J
    Rev Esp Fisiol; 1988 Jun; 44(2):227-9. PubMed ID: 2904157
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue protein turnover in animals treated with the mixed beta-agonist metaproterenol: influence of dose, route and pattern of administration.
    Pascual M; Del Barrio AS; Portillo MP; Martinez JA; Larralde J
    Biochimie; 1993; 75(10):879-83. PubMed ID: 7508755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats.
    Morifuji M; Sanbongi C; Sugiura K
    Br J Nutr; 2006 Sep; 96(3):469-75. PubMed ID: 16925851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
    Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in lean tissue and body fat associated with anabolic hormone administration.
    GILDER H; CORNELL GN; JOHNSON G; CRAVER WL; BEAL JM
    Surg Forum; 1957; 8():58-61. PubMed ID: 13529547
    [No Abstract]   [Full Text] [Related]  

  • 15. Presence of adipose fat as a criterion of implant compatibility.
    Kaminski EJ; Shenk MW; Oglesby RJ
    Ill Dent J; 1978 Jun; 47(6):314-7. PubMed ID: 285016
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
    Costelli P; García-Martínez C; Llovera M; Carbó N; López-Soriano FJ; Agell N; Tessitore L; Baccino FM; Argilés JM
    J Clin Invest; 1995 May; 95(5):2367-72. PubMed ID: 7738199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homeorrhetic modifications produced by a beta-agonist in the muscle and adipose tissues of the rat].
    Portillo MP; Martinez JA; Larralde J
    Reprod Nutr Dev; 1991; 31(5):509-19. PubMed ID: 1768309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic actions of a mixed beta-adrenergic agonist on nitrogen retention and protein turnover.
    Martinez JA; Portillo MP; Larralde J
    Horm Metab Res; 1991 Dec; 23(12):590-3. PubMed ID: 1723394
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.